Rasvumine kliinilised uuringud osariigis Kansas
32 uuringut haiguse Rasvumine jaoks otsivad osalejaid osariigis Kansas.
Linnad osariigis Kansas
Ametlik uuringutekst (inglise keeles)
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Cotton O'Neil Clinical Research Center, Topeka
VärbamineFaas 3
Vanused 8–18 · Kõik sood · Uuendatud 30. sept 2026 · NCT07253285Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- AMR Clinical - Wichita, Wichita
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07685808A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Cotton O'Neil Diabetes & Endocrinology, Topeka
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Lenexa
- Research Site, Newton
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Cotton-ONeil Diabetes and Endocrinology Center, Topeka
VärbamineFaas 3
Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Cotton O'Neil Clinical Research Center, Topeka
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07321886Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- AMR Clinical, Newton
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Cotton O'Neil Diabetes & Endocrinology, Topeka
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 22. sept 2026 · NCT07589608A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Kansas City
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Kansas City
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- University of Kansas Medical Center, Kansas City
- Johnson County Clintrials, Lenexa
- Kansas Nephrology Research Institute LLC, Wichita
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 16. sept 2026 · NCT07037459A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Wichita
VärbamineFaas 3Terved vabatahtlikud oodatud
Vanused 18–79 · Kõik sood · Uuendatud 11. sept 2026 · NCT07654374A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Cotton O'Neil Diabetes & Endocrinology, Topeka
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 8. sept 2026 · NCT06143956A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
- ICON Early Phase Services, LLC, Lenexa
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–55 · Kõik sood · Uuendatud 4. sept 2026 · NCT07767175Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Newton
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Alliance for Multispecialty Research Newton, Newton
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Alliance for Multispecialty Research Newton, Newton
- Alliance for Multispecialty Research LLC, Wichita
VärbamineFaas 3
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684144Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Newton
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07284979Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Mercy Hospital, Kansas City
VärbamineFaas 2
Vanused 7–25 · Kõik sood · Uuendatud 19. aug 2026 · NCT05082519A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- West Houston Area Clinical Trial Consultants, Wichita
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 18. aug 2026 · NCT07567001Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
- University of Kansas Medical Center, Kansas City
Värbamine
Vanused 18–35 · Kõik sood · Uuendatud 11. aug 2026 · NCT06961591Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Wichita
VärbamineFaas 3
Vanused 18–79 · Kõik sood · Uuendatud 10. aug 2026 · NCT07654361Gestational Response, Outcomes, and Weight After GLP-1 Use
- University of Kansas Medical Center, Kansas City
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 18–45 · Naised · Uuendatud 4. aug 2026 · NCT07743567A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
- ICON Early Phase Services, LLC, Lenexa
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–55 · Kõik sood · Uuendatud 29. juuli 2026 · NCT07437079Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise
- University of Kansas Medical Center, Kansas City
Värbamine
Vanused 18–64 · Kõik sood · Uuendatud 15. juuli 2026 · NCT07698145Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)
- University of Kansas Medical Center, Kansas City
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. juuli 2026 · NCT06640179Muscle and Movement With Anti-Obesity Medications
- University of Kansas Medical Center, Kansas City
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. mai 2026 · NCT06645470A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- Altasciences Clinical Kansas, Inc., Overland Park
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 21. apr 2026 · NCT07395687Brain Outcomes With Lifestyle Change in Down Syndrome
- University of Kansas Medical Center, Kansas City
Värbamine
Vanused 18–64 · Kõik sood · Uuendatud 11. märts 2026 · NCT05985486Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.
- University of Kansas Medical Center, Kansas City
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. jaan 2026 · NCT06636773Mitigating the Pro-inflammatory Phenotype of Obesity
- University of Kansas Medical Center, Kansas City
VärbamineFaas 1
Vanused 18–79 · Kõik sood · Uuendatud 5. juuni 2025 · NCT04934228Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension
- University of Kansas Medical Center, Kansas City
VärbamineVaatlusuuring
Vanused 18–79 · Kõik sood · Uuendatud 3. okt 2024 · NCT06626113Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.